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Human Bocavirus 
DNA in Paranasal 
Sinus Mucosa
To the Editor: Human bocavirus 
(HBoV) is a newly described parvovirus 
for which pathogenic potential has 
not clearly been elucidated (1). 
Recent fi ndings suggest that HBoV 
may establish persistent infection of 
mucosal lymphocytes or contribute 
to tonsillar hyperplasia in children 
(2). In previous reports, we described 
prolonged HBoV DNA detection in 
immunocompromised children (3,4). 
Partial sequencing of the VP1 gene of 
HBoV from bronchoalveolar lavage 
fl uid, plasma, and sphenoid sinus 
samples showed 100% identity, which 
suggested persistence of the same 
HBoV strain over a 5-month period 
(3). It remains speculative, however, 
whether paranasal sinus mucosa 
represents a site of HBoV persistence. 
To clarify this, we analyzed samples 
of paranasal mucosal tissue and nasal 
polyps from patients with chronic 
sinusitis for respiratory viruses and 
atypical bacteria.
A total of 102 tissue samples 
were obtained from 88 patients 
(median age 48.5 years, range 13.3–
88.1 years) from July 2009 through 
September 2010 after elective surgery. 
Indication for surgery was established 
by otorhinolaryngologists. The most 
common indication was chronic 
sinusitis. No patients displayed acute 
respiratory symptoms at the time 
of surgery. To detect asymptomatic 
shedding in the upper respiratory 
tract and viremia, we collected nasal 
swabs and EDTA-blood samples 
concurrently. The study protocol was 
approved by the Ethics Committee of 
the University of Freiburg. Informed 
written consent was obtained from all 
study participants.
Approximately 25 mg of each 
tissue specimen was used for nucleic 
acid extraction by using an RNeasy 
Mini Kit, as described (5) (QIAGEN, 
Hamburg, Germany). To provide 
evidence that the QIAGEN RNeasy 
kit is also suitable for DNA extraction, 
we spiked HBoV negative samples 
with different amounts of HBoV DNA 
before extraction of nucleic acids was 
done with either the QIAGEN RNeasy 
Kit or DNA Blood Kit (QIAGEN). 
Extracted nucleic acids were then 
subjected to real-time PCR by using 
primers specifi c for HBoV. Minimal 
differences (±1 cycle threshold 
[Ct] value) in the HBoV PCR were 
detected; the QIAGEN RNeasy Kit 
was therefore used throughout the 
study (data not shown). Nasal swabs 
and EDTA-blood were purifi ed by 
using a QIAamp MinElute Virus 
Spin Kit (QIAGEN). Multiplex PCR 
for respiratory viruses (Fast-track 
Diagnostics, Junglinster, Luxembourg) 
was conducted to detect infl uenza A 
(including pandemic [H1N1] 2009) 
and B viruses; respiratory syncytial 
virus; human metapneumovirus; 
HBoV; parainfl uenza virus 1–4; 
human coronaviruses HKU1, 
NL63, 229E, and OC43; human 
rhinoviruses; human enteroviruses 
and parechoviruses; and adenoviruses. 
Mycoplasma pneumoniae, Chlamydia 
pneumoniae, Legionella pneumophila, 
and Bordetella pertussis were analyzed 
as described (6–8).
A single virus was detected in 
22/102 (21.5%) tissue specimens, 
with HBoV being the most frequent 
(18/102, 17.6%), followed by 
rhinovirus (2/102, 1.9%), coronavirus 
229E, and infl uenza A pandemic 
(H1N1) 2009 virus (1/102, 0.9%). 
HBoV was detected in specimens 
collected during July–September 
(13/18) and during February and 
March (5/18). All positive results 
were confi rmed by single real-time 
PCR (9). For 14 patients, 2 different 
mucosal samples were tested and 
gave identical results. No multiple 
viral infections and no bacteria were 
detected. Median patient age was 
51.2 years (range 14.4–74.2 years) for 
HBoV-positive and 47.6 years (range 
13.3–88.1 years) for HBoV-negative 
samples. Ct analysis in single real-
time PCR revealed a median Ct of 
31 (range 28–38), corresponding to 
200 genome equivalents/106 cells 
(range 3–1.8 × 104 copies/106 cells). 
No correlation between Ct value 
and patients’ age was observed 
(r2 = 0.008; data not shown). No 
underlying disease was diagnosed 
for 13/18 HBoV-positive patients, 
whereas 2/18 and 3/18 patients had 
chronic obstructive pulmonary and 
oncologic disease, respectively.
Nasal swabs and EDTA-blood 
samples were obtained from 17/18 
and 7/18 HBoV-positive patients, 
respectively. No HBoV was detected 
in any swabs or EDTA-blood samples 
available, indicating no virus shedding 
in the respiratory tract and no 
viremia. However, the 2 patients with 
rhinovirus-positive samples obtained 
from biopsy also had rhinovirus RNA 
detectable in nasal swabs, suggesting 
rhinovirus infection. Unfortunately, 
no nasal swab was available from the 
2 patients whose sinus biopsy samples 
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were positive for HCoV 229E and 
infl uenza A virus.
In this study, we simultaneously 
analyzed tissue specimens of paranasal 
sinuses and nasal polyps, as well as 
nasal swabs and blood samples, for 
a broad panel of viruses and atypical 
bacteria. To avoid seasonal bias, 
specimens were collected over a 1-year 
period and exclusively obtained from 
patients undergoing elective surgery 
in the absence of acute respiratory 
symptoms.
The fi nding that HBoV was 
present as a single virus in 18/22 virus-
positive biopsy samples is intriguing. 
Moreover, the fact that no HBoV DNA 
was detected in nasal swabs or EDTA-
blood samples indicates no active 
HBoV infection. In previous studies, 
HBoV DNA was frequently identifi ed 
in the adenoids and tonsils of children 
(2,5,10). However, in contrast with 
our fi ndings, detection of HBoV was 
mostly associated with other viruses, 
suggesting that co-virus–induced 
cellular damage might contribute 
to bocavirus reactivation and 
replication (5). Our fi ndings indicate 
that persistence of viral nucleic acid 
in sinus mucosa might be a special 
advantage of HBoV, although the 
relevance of this observation remains 
unclear. Whether this presence as 
a single virus means a dead end 
for HBoV infection, true latency 
including the potential of reactivation, 
or a role in the pathogenesis of clinical 
conditions requiring surgery warrants 
future studies. 
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Hepatitis C Virus, 
Pakistan
To the Editor: The prevalence of 
hepatitis C virus (HCV) infection is 
high (8% of the population) in Pakistan 
(1). HCV is an RNA virus that has a 
high mutation rate. This high rate results 
in extensive genetic heterogeneity, 
and HCV isolates are found as either 
quasispecies or genotypes (2). Humans 
can be co-infected with >1 genotype 
(mixed genotype infection) of this 
virus (3). The rate of HCV mixed 
genotype infections is extremely 
variable for different regions and for 
the same group of patients tested by 
using different assays (4). Thus, it is 
diffi cult to determine the prevalence of 
mixed genotype infections by currently 
available assays, including direct DNA 
sequencing, because they are designed 
to identify only the HCV genotype 
dominant in that particular population. 
Consequently, genotypes present at 
lower frequencies could be missed or 
mistyped (5).
To determine the prevalence of 
HCV mixed genotype infections, we 
retrospectively analyzed genotyping 
data for paired serum samples from 
22,125 HCV-infected patients during 
the past 11 years (March 2000–May 
2010) for all regions in Pakistan by 
using molecular-based genotype-
specifi c methods (6,7). A total of 
12,036 (54.4%) were male patients 
and 10,089 (45.6%) were female 
patients.
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